share_log

ShockWave Medical Analyst Ratings

ShockWave Medical Analyst Ratings

ShochWave 医学分析师评级
Benzinga Analyst Ratings ·  2023/01/26 06:46
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
01/26/2023 46.94% Piper Sandler $300 → $280 Maintains Overweight
01/06/2023 17.55% Morgan Stanley $290 → $224 Maintains Equal-Weight
12/12/2022 23.33% Wells Fargo → $235 Downgrades Overweight → Equal-Weight
11/08/2022 57.44% Wells Fargo $255 → $300 Maintains Overweight
10/11/2022 52.19% Morgan Stanley $255 → $290 Maintains Equal-Weight
09/06/2022 -13.41% Oppenheimer → $165 Downgrades Perform → Underperform
08/29/2022 77.38% Piper Sandler $278 → $338 Maintains Overweight
08/09/2022 33.82% Morgan Stanley $201 → $255 Maintains Equal-Weight
08/09/2022 33.82% Wells Fargo $176 → $255 Maintains Overweight
08/09/2022 45.89% Piper Sandler $245 → $278 Maintains Overweight
07/15/2022 5.48% Morgan Stanley $180 → $201 Maintains Equal-Weight
05/10/2022 -5.54% Morgan Stanley $199 → $180 Maintains Equal-Weight
05/10/2022 -7.64% Wells Fargo $235 → $176 Maintains Overweight
05/10/2022 -8.16% SVB Leerink $250 → $175 Maintains Outperform
04/06/2022 33.82% Wolfe Research → $255 Initiates Coverage On → Outperform
02/18/2022 4.43% Morgan Stanley $210 → $199 Maintains Equal-Weight
02/18/2022 -0.29% SVB Leerink $160 → $190 Maintains Outperform
01/07/2022 10.21% Morgan Stanley $204 → $210 Maintains Equal-Weight
12/06/2021 23.33% Wells Fargo → $235 Upgrades Equal-Weight → Overweight
11/09/2021 23.33% Wells Fargo $200 → $235 Maintains Equal-Weight
11/09/2021 39.07% SVB Leerink $250 → $265 Maintains Outperform
08/10/2021 4.96% Morgan Stanley $152 → $200 Maintains Equal-Weight
08/10/2021 15.46% SVB Leerink $208 → $220 Maintains Outperform
07/15/2021 9.16% SVB Leerink → $208 Initiates Coverage On → Outperform
07/12/2021 4.96% B of A Securities $180 → $200 Downgrades Buy → Neutral
06/18/2021 -0.81% Wells Fargo → $189 Downgrades Overweight → Equal-Weight
06/07/2021 -0.81% Wells Fargo $161 → $189 Maintains Overweight
05/11/2021 6.01% Canaccord Genuity $149 → $202 Maintains Buy
05/11/2021 -20.23% Morgan Stanley $145 → $152 Maintains Equal-Weight
05/11/2021 -15.51% Wells Fargo $151 → $161 Maintains Overweight
05/11/2021 -5.54% B of A Securities → $180 Upgrades Neutral → Buy
04/19/2021 -23.9% Morgan Stanley $130 → $145 Maintains Equal-Weight
03/31/2021 -21.81% Canaccord Genuity $147 → $149 Maintains Buy
02/22/2021 -31.78% Morgan Stanley $103 → $130 Maintains Equal-Weight
02/19/2021 -31.78% Morgan Stanley $103 → $130 Maintains Equal-Weight
02/18/2021 -29.68% Piper Sandler $132 → $134 Maintains Neutral
02/02/2021 -31.25% Canaccord Genuity $87 → $131 Maintains Buy
01/20/2021 -30.73% Piper Sandler $96 → $132 Downgrades Overweight → Neutral
12/15/2020 -45.95% Morgan Stanley $89 → $103 Maintains Equal-Weight
11/11/2020 -53.29% Morgan Stanley $72 → $89 Maintains Equal-Weight
10/19/2020 -62.21% Morgan Stanley $55 → $72 Maintains Equal-Weight
10/16/2020 -52.77% Wells Fargo $80 → $90 Maintains Overweight
08/12/2020 -69.56% Piper Sandler $54 → $58 Maintains Overweight
08/12/2020 -71.14% Morgan Stanley $42 → $55 Maintains Equal-Weight
06/11/2020 — Oppenheimer Upgrades Underperform → Perform
06/09/2020 -72.19% Canaccord Genuity $46 → $53 Maintains Buy
05/13/2020 -77.96% Morgan Stanley $40 → $42 Maintains Equal-Weight
05/13/2020 -75.86% Wells Fargo $43 → $46 Maintains Overweight
04/01/2020 -87.93% Oppenheimer → $23 Downgrades Perform → Underperform
03/27/2020 -79.01% Morgan Stanley $51 → $40 Maintains Equal-Weight
12/17/2019 -75.33% Morgan Stanley $35 → $47 Maintains Equal-Weight
12/12/2019 — Wells Fargo Upgrades Equal-Weight → Overweight
11/08/2019 -81.63% Morgan Stanley $32 → $35 Maintains Equal-Weight
10/22/2019 — Oppenheimer Initiates Coverage On → Perform
10/21/2019 -79.53% Piper Sandler → $39 Initiates Coverage On → Overweight
04/01/2019 -82.68% Wells Fargo → $33 Initiates Coverage On → Market Perform
04/01/2019 — Morgan Stanley Initiates Coverage On → Equal-Weight
日期 上行/下行 分析公司 目标价格变化 评级变化 上一次/当前评级
01/26/2023 46.94% 派珀·桑德勒 $300 → $280 维护 超重
01/06/2023 17.55% 摩根士丹利 $290 → $224 维护 等重
12/12/2022 23.33% 富国银行 → $235 评级下调 超重→等重
11/08/2022 57.44% 富国银行 $255 → $300 维护 超重
10/11/2022 52.19% 摩根士丹利 $255 → $290 维护 等重
09/06/2022 -13.41% 奥本海默 → $165 评级下调 执行→未充分执行
08/29/2022 77.38% 派珀·桑德勒 $278 → $338 维护 超重
08/09/2022 33.82% 摩根士丹利 $201 → $255 维护 等重
08/09/2022 33.82% 富国银行 $176 → $255 维护 超重
08/09/2022 45.89% 派珀·桑德勒 $245 → $278 维护 超重
07/15/2022 5.48% 摩根士丹利 $180 → $201 维护 等重
05/10/2022 -5.54% 摩根士丹利 $199 → $180 维护 等重
05/10/2022 -7.64% 富国银行 $235 → $176 维护 超重
05/10/2022 -8.16% SVB Leerink $250 → $175 维护 跑赢大盘
04/06/2022 33.82% 沃尔夫研究 → $255 开始承保 →跑赢大盘
02/18/2022 4.43% 摩根士丹利 $210 → $199 维护 等重
02/18/2022 -0.29% SVB Leerink $160 → $190 维护 跑赢大盘
01/07/2022 10.21% 摩根士丹利 $204 → $210 维护 等重
12/06/2021 23.33% 富国银行 → $235 升级 等重→超重
11/09/2021 23.33% 富国银行 $200 → $235 维护 等重
11/09/2021 39.07% SVB Leerink $250 → $265 维护 跑赢大盘
08/10/2021 4.96% 摩根士丹利 $152 → $200 维护 等重
08/10/2021 15.46% SVB Leerink $208 → $220 维护 跑赢大盘
07/15/2021 9.16% SVB Leerink → $208 开始承保 →跑赢大盘
07/12/2021 4.96% B of A证券 $180 → $200 评级下调 购买→中性
06/18/2021 -0.81% 富国银行 → $189 评级下调 超重→等重
06/07/2021 -0.81% 富国银行 $161 → $189 维护 超重
05/11/2021 6.01% 卡纳科特·格纳奇 $149 → $202 维护 买
05/11/2021 -20.23% 摩根士丹利 $145 → $152 维护 等重
05/11/2021 -15.51% 富国银行 $151 → $161 维护 超重
05/11/2021 -5.54% B of A证券 → $180 升级 中性→购买
04/19/2021 -23.9% 摩根士丹利 $130 → $145 维护 等重
03/31/2021 -21.81% 卡纳科特·格纳奇 $147 → $149 维护 买
02/22/2021 -31.78% 摩根士丹利 $103 → $130 维护 等重
02/19/2021 -31.78% 摩根士丹利 $103 → $130 维护 等重
02/18/2021 -29.68% 派珀·桑德勒 $132 → $134 维护 中性
02/02/2021 -31.25% 卡纳科特·格纳奇 $87 → $131 维护 买
01/20/2021 -30.73% 派珀·桑德勒 $96 → $132 评级下调 超重→中性
12/15/2020 -45.95% 摩根士丹利 $89 → $103 维护 等重
11/11/2020 -53.29% 摩根士丹利 $72 → $89 维护 等重
10/19/2020 -62.21% 摩根士丹利 $55 → $72 维护 等重
10/16/2020 -52.77% 富国银行 $80 → $90 维护 超重
08/12/2020 -69.56% 派珀·桑德勒 $54 → $58 维护 超重
08/12/2020 -71.14% 摩根士丹利 $42 → $55 维护 等重
06/11/2020 — 奥本海默 升级 表现逊于→表现
06/09/2020 -72.19% 卡纳科特·格纳奇 $46 → $53 维护 买
05/13/2020 -77.96% 摩根士丹利 $40 → $42 维护 等重
05/13/2020 -75.86% 富国银行 $43 → $46 维护 超重
04/01/2020 -87.93% 奥本海默 → $23 评级下调 执行→未充分执行
03/27/2020 -79.01% 摩根士丹利 $51 → $40 维护 等重
12/17/2019 -75.33% 摩根士丹利 $35 → $47 维护 等重
12/12/2019 — 富国银行 升级 等重→超重
11/08/2019 -81.63% 摩根士丹利 $32 → $35 维护 等重
10/22/2019 — 奥本海默 开始承保 →性能
10/21/2019 -79.53% 派珀·桑德勒 → $39 开始承保 →超重
04/01/2019 -82.68% 富国银行 → $33 开始承保 →市场表现
04/01/2019 — 摩根士丹利 开始承保 →等重

What is the target price for ShockWave Medical (SWAV)?

冲击波医疗(SWAV)的目标价是多少？

The latest price target for ShockWave Medical (NASDAQ: SWAV) was reported by Piper Sandler on January 26, 2023. The analyst firm set a price target for $280.00 expecting SWAV to rise to within 12 months (a possible 46.94% upside). 17 analyst firms have reported ratings in the last year.

派珀·桑德勒于2023年1月26日报道了冲击波医疗(纳斯达克：SWAV)的最新目标价。这家分析公司将目标价定为280.00美元，预计SWAV12个月内将升至46.94%。过去一年，17家分析公司公布了评级。

What is the most recent analyst rating for ShockWave Medical (SWAV)?

Shockwave Medical(SWAV)的最新分析师评级是多少？

The latest analyst rating for ShockWave Medical (NASDAQ: SWAV) was provided by Piper Sandler, and ShockWave Medical maintained their overweight rating.

纳斯达克(Sequoia Capital)的最新分析师评级由派珀·桑德勒提供，冲击波医疗维持其增持评级。

When is the next analyst rating going to be posted or updated for ShockWave Medical (SWAV)?

Shockwave Medical(SWAV)的下一次分析师评级将于何时发布或更新？

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of ShockWave Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for ShockWave Medical was filed on January 26, 2023 so you should expect the next rating to be made available sometime around January 26, 2024.

分析师在进行了广泛的研究后得出了股票评级，其中包括查阅公共财务报表，与Shockwave Medical的高管和客户交谈，以及收听收益电话会议。大多数分析师每三个月就会这样做一次，所以你每年应该会得到每家公司每家公司的4个评级。Shockwave Medical的上一次评级是在2023年1月26日提交的，所以你应该预计下一次评级将在2024年1月26日左右的某个时候提供。

Is the Analyst Rating ShockWave Medical (SWAV) correct?

分析师对Shockwave Medical(SWAV)的评级正确吗？

While ratings are subjective and will change, the latest ShockWave Medical (SWAV) rating was a maintained with a price target of $300.00 to $280.00. The current price ShockWave Medical (SWAV) is trading at is $190.55, which is out of the analyst's predicted range.

虽然评级是主观的，并将发生变化，但最新的冲击波医疗评级维持不变，目标价在300.00美元至280.00美元之间。目前冲击波医疗的交易价格为190.55美元，超出了分析师的预测范围。

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发